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TehB is an S-adenosyl-l-methionine (SAM) dependent methyltransferase that
detoxifies tellurite in bacteria. The Escherichia coli TehB protein was purified
and crystallized in the presence of both SAM and sinefungin. The TehB–SAM
and TehB–sinefungin crystals both diffracted X-rays to 1.9 A˚ resolution. The
TehB–SAM crystals belonged to space group C2, with unit-cell parameters
a = 60.0, b = 56.1, c = 130.6 A˚,  = 97.9. The TehB–sinefungin crystals belonged
to space group P21, with unit-cell parameters a = 59.1, b = 55.5, c = 129.7 A˚,
 = 95.9.
1. Introduction
Tellurite (TeO3
2) is found in low abundance in the environment
(Taylor, 1999). It has been found to be very toxic to the majority of
bacteria, with only small quantities being required for a detrimental
effect on microorganisms (Silver, 1998; Taylor, 1999). Tellurite tox-
icity has been suggested to be a result of the generation of reactive
oxygen species (ROS; Perez et al., 2007) that act as strong oxidizing
agents and can lead to the oxidation of many cellular thiols (Turner
et al., 1999), disrupting and causing the stoppage of protein/DNA
synthesis and many reductases. Tellurite has also been suggested to
replace sulfur in various biological reactions, with fatal effects on the
cell (Taylor, 1999).
Bacteria have developed mechanisms that can detoxify tellurite
either by reducing it to elemental tellurium (Te0) or by methylation.
Elemental tellurium is insoluble in water and appears as black
deposits within cells (Borsetti et al., 2003; Baesman et al., 2007). In
Escherichia coli the periplasmic nitrate reductase NapA has been
associated with the reduction of tellurium to tellurite with the aid of a
membrane-bound nitrate reductase (Avazeri et al., 1997). Methylated
tellurite has been detected as a volatile gas in GC/MS headspace
gas analysis in bacteria that harbour plasmids that express methyl-
transferases (Cournoyer et al., 1998; Ollivier et al., 2008).
In E. coli, the membrane-bound protein TehA and the cytoplasmic
methyltransferase TehB have been reported as the tellurite-resistance
proteins (Turner et al., 1995, 1997; Liu et al., 2000; Dyllick-Brenzinger
et al., 2000). Liu et al. (2000) showed that TehB is a SAM-dependent
methyltransferase and that tellurite can be methylated. In their study,
they did not detect any volatile tellurite species. The modification and
removal of tellurite by TehA and TehB occurs continuously.
In this study, TehB from E. coli has been purified and crystallized in
the presence of SAM and of sinefungin (a SAM analogue) and data
have been collected to 1.9 A˚ resolution for both complexes. We aim
to determine the structure of the TehB enzyme and to shed light on
the detailed mechanism of this methyltransferase.
2. Materials and methods
2.1. Production of native TehB
The tehB gene (gene identifier b1430) from E. coli MG1655 was
cloned into the pEHis/TEV vector (Liu & Naismith, 2009), forming a
tehB plasmid construct containing an N-terminal His6-tag sequence
followed by a TEV (tobacco etch mosaic virus) protease cleavage site
between the His tag and TehB. The tehB plasmid was transformed
and expressed in E. coli BL21 (DE3) PlysS host cells.
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A freshly transformed colony was selected and used to inoculate
10 ml sterilized LB medium containing 34 mg ml1 kanamycin. The
cell culture was grown overnight with shaking at 200 rev min1 at
310 K. The overnight culture was used to inoculate 1 l sterilized LB
medium containing 34 mg ml1 kanamycin in a 2.5 l baffled flask. The
culture was shaken at 200 rev min1 at 310 K until the OD600 reached
0.8 and overexpression was induced using 1 mM isopropyl -d-1-
thiogalactopyranoside for 4 h at 310 K. The cells were harvested at
6200g for 10 min at 277 K. The cell pellet was collected and stored at
213 K.
2.2. Protein purification
The cell pellet was resuspended in 200 ml 1 ice-cold phosphate-
buffered saline (PBS) containing 0.1 mg ml1 Pefabloc SC (Sigma),
20 U ml1 DNase (Sigma) and 1 mM magnesium chloride. The cells
were passed twice through a cell disruptor (Constant Systems) at 151
and 172 MPa. The residual unbroken cells, cellular debris and cell
membranes were removed by centrifugation at 150 000g for 1 h. The
supernatant containing the soluble protein fraction was collected. All
subsequent steps were performed at 277 K.
The supernatant was brought to 20 mM imidazole in PBS and
passed over a 5 ml His-Trap column HP (GE Healthcare) equili-
brated with 20 mM imidazole in PBS. The column was then washed
with five column volumes of 20 mM imidazole in PBS and finally with
five column volumes of 30 mM imidazole in PBS. The protein was
eluted with five column volumes of 500 mM imidazole in PBS. The
protein was incubated with TEV protease at a 1:100 TEV protease:
protein concentration ratio while being dialysed in 4 l gel-filtration
buffer consisting of 20 mM Tris pH 7.5, 150 mM sodium chloride,
1 mM DTT and 5 mM ethylenediaminetetraacetic acid (EDTA)
overnight.
The cleaved material was passed through a His-Trap column
equilibrated with gel-filtration buffer to remove TEV protease, His6
tag and any uncleaved protein. The flowthrough containing the
cleaved protein was collected. The column was washed with a further
10 ml of buffer and collected. The flowthrough was concentrated to
500 ml using a 10 kDa cutoff concentrator (Millipore).
The concentrated protein was injected onto a Superdex 75 10/300
GL column (GE Healthcare) equilibrated with gel-filtration buffer
without EDTA and DTT. A single peak containing TehB was
observed on the chromatogram. The fraction containing TehB was
analysed by SDS–PAGE and concentrated to 17 mg ml1 using a
10 kDa cutoff concentrator (Millipore).
2.3. Crystallization
Initial crystallization screens were carried out with and without
adding 1 mM SAM (Sigma) to the protein. Vapour diffusion in sitting
drops was used to screen for initial conditions using a 96-well
Innovadyne plate at 293 and 277 K. Conditions were screened using
the PACTand JCSG+ (Qiagen) screens. The plates were set up using
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Figure 1
(a) Initial TehB crystals obtained in the presence of 1 mM SAM. (b) Single TehB
crystal after microseeding. (c) TehB crystal obtained in the presence of 5 mM
sinefungin after microseeding.
Figure 2
Diffraction pattern of TehB–SAM. The blue circle indicates the diffraction limit at
1.9 A˚ resolution. The inset shows the spots at high resolution.
a Mosquito robot (TTP Labtech) to dispense drops consisting of
100 nl protein solution and 100 nl precipitant solution.
Initial crystals of TehB containing SAM (TehB–SAM) appeared
after 4 d in 0.2M NaF, 22% PEG 3350 at 293 K. Optimized crystal-
lization condition screening was carried out by hanging-drop vapour
diffusion using a 24-well Linbro plate (Hamilton Research), mixing
1 ml protein solution and 1 ml precipitant solution. Crystals appeared
as multiple crystal clusters that were joined together (Fig. 1a). The
addition of additives did not improve the crystal quality. Seeding was
then carried out to try to obtain single crystals. A 2% lower PEG
concentration than the optimal condition was used as the new
precipitant condition (0.1M NaF and 16% PEG 3350). Crystals from
a single drop containing 0.1M NaF and 18% PEG 3350 were taken,
placed in 10 ml crystallization buffer and vortexed for a few minutes.
0.5 ml of this seed stock was added to a drop consisting of 1 ml protein
solution mixed with 1 ml precipitant solution. Single large crystals
were obtained overnight (Fig. 1b). TehB was also crystallized in the
presence of 5 mM sinefungin (Sigma), a known cofactor analogue of
SAM (Schluckebier et al., 1997), under similar conditions as used for
the TehB–SAM crystals: 0.1M NaF and 16% PEG 3350. Micro-
seeding was essential to obtain single crystals (Fig. 1c).
2.4. Data collection and processing
The crystals were transferred into paraffin oil for cryoprotection
before being frozen in liquid nitrogen for storage and data collection.
The TehB–SAM data were collected on beamline I04 with a wave-
length of 1 A˚ (Fig. 2) and the TehB–sinefungin data were collected on
beamline I03 with a wavelength of 0.97 A˚ at 100 K at Diamond Light
Source. The data sets were collected using a CCD detector (ADSC
Q315 CCD). All data were collected using a 0.5 oscillation range.
The data were processed using XDS (Kabsch, 2010) and scaled using
SCALA (Evans, 1993) under the xia2 interface (Winter, 2010). The
data-collection statistics are summarized in Table 1.
3. Results and discussion
The crystals of TehB–SAM belonged to space group C2 and those of
TehB–sinefungin belonged to space group P21. The asymmetric unit
of the TehB–SAM crystals was calculated to contain two molecules
(VM = 2.16 A˚
3 Da1), with an estimated solvent content of 43.2%.
The asymmetric unit of the TehB–sinefungin crystals was calculated
to contain four molecules (VM = 2.39 A˚
3 Da1), with an estimated
solvent content of 48.5%. Molecular replacement of TehB–SAM
using a putative methyltransferase from Salmonella typhimurium LT2
(PDB code 2i6g; Joint Centre for Structural Genomics, unpublished
work) as a model was performed using Phaser (McCoy et al., 2007).
The two sequences share 91% homology and 84% identity. A
sequence alignment of the two sequences is shown in Fig. 3. Mole-
cular replacement located two copies of the putative methyl-
transferase within the asymmetric unit of TehB–SAM and four copies
within the asymmetric unit of TehB–sinefungin, with Z scores of 33.4
and 39.5, respectively. Model building and refinement of both com-
plexes is currently under way.
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Figure 3
Sequence alignment of TehB from E. coli with the putative methyltransferase from S. typhimurium LT2. Conserved residues are shown in red boxes and the secondary
structure is shown at the top of the sequence.
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